The AI boom has been loud. The quantum whisper? That’s been SandboxAQ, quietly building something so advanced, most folks don’t even know how far behind they already are.
Started inside Alphabet back in 2016 as an internal skunkworks lab, SandboxAQ spun out in 2022 with a mission that reads like science fiction, but executes like enterprise-grade SaaS. Quantum resistant cryptography? Check. Physics-based AI simulations that model molecular interactions faster than your GPU can blink? Check. Navigation systems that work without GPS by reading the Earth’s magnetic fingerprint like a mixtape? Yeah, that too.
And now, fresh off a $95 million secondary offering, led by Rizvi Traverse Management, Forge Global, and Ava Family Office, SandboxAQ isn’t slowing down. This round isn’t about survival cash. It’s about giving the team room to breathe, move, and build. Because when you’re sitting on a $5.6 billion valuation and have major institutions like Google, NVIDIA, Ray Dalio, BNP Paribas, and Horizon Kinetics already in your corner, you’re not pitching, you’re executing.
Founder and CEO Jack D. Hidary, a serial entrepreneur and the author of Quantum Computing: An Applied Approach (aka the textbook your CTO pretends they’ve read), isn’t just steering the ship, he’s laying the foundation for post-quantum infrastructure across cybersecurity, drug discovery, national defense, and more. With Eric Schmidt, former CEO of Alphabet, serving as Chairman, and seasoned operators like David Silverman (CFO), Andrew McLaughlin (COO), and Jen Sovada (President, Public Sector) rounding out the squad, this is a company that’s playing 4D chess while the rest of the room is arguing over checkers.
Let’s not breeze past what matters here: SandboxAQ has figured out how to merge physics-grounded AI (they call it Large Quantitative Models) with practical quantum-inspired engineering. It’s not hype, it’s deployment-ready tech already running inside Vodafone Business, Mt. Sinai Health System, SoftBank, and key government agencies. Their AQtive Guard platform? Already SOC2 Type II certified and automating cryptographic risk like it’s Excel macros on steroids. AQBioSim and AQChemSim? Helping pharma model new treatments at speeds that make legacy R&D look like it’s powered by AOL dial-up.
This isn’t just a moonshot, it’s a new operating system for science and security. And if your business touches data, chemistry, code, or communications, you’ll either adopt this tech, or get left in the dust of its acceleration curve.
